ATE293444T1 - Zusammensetzung und verfahren zur parenteralen anwendung von ibuprofen-d,l-, oder l-lysinat - Google Patents

Zusammensetzung und verfahren zur parenteralen anwendung von ibuprofen-d,l-, oder l-lysinat

Info

Publication number
ATE293444T1
ATE293444T1 AT01126687T AT01126687T ATE293444T1 AT E293444 T1 ATE293444 T1 AT E293444T1 AT 01126687 T AT01126687 T AT 01126687T AT 01126687 T AT01126687 T AT 01126687T AT E293444 T1 ATE293444 T1 AT E293444T1
Authority
AT
Austria
Prior art keywords
ibuprofen
absence
active ingredient
inert atmosphere
disclosed
Prior art date
Application number
AT01126687T
Other languages
English (en)
Inventor
Laszlo Darko
Original Assignee
Farmacon Il Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmacon Il Llc filed Critical Farmacon Il Llc
Application granted granted Critical
Publication of ATE293444T1 publication Critical patent/ATE293444T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT01126687T 2000-11-14 2001-11-08 Zusammensetzung und verfahren zur parenteralen anwendung von ibuprofen-d,l-, oder l-lysinat ATE293444T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/712,430 US6342530B1 (en) 2000-11-14 2000-11-14 Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt

Publications (1)

Publication Number Publication Date
ATE293444T1 true ATE293444T1 (de) 2005-05-15

Family

ID=24862079

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01126687T ATE293444T1 (de) 2000-11-14 2001-11-08 Zusammensetzung und verfahren zur parenteralen anwendung von ibuprofen-d,l-, oder l-lysinat

Country Status (7)

Country Link
US (1) US6342530B1 (de)
EP (1) EP1205181B9 (de)
JP (1) JP2002193799A (de)
AT (1) ATE293444T1 (de)
CA (1) CA2361160A1 (de)
DE (1) DE60110185T2 (de)
MX (1) MXPA01011629A (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040132823A1 (en) * 2001-11-02 2004-07-08 Leo Pavliv Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
RU2340334C2 (ru) * 2002-10-25 2008-12-10 Домпе С.П.А. Безболезненные инъецируемые композиции, содержащие соли 2-арилпропионовых кислот
US6753350B1 (en) 2003-03-24 2004-06-22 Bristol-Myers Squibb Company Method to reduce the incidence of intraventricular hemorrhage in preterm infants
US20050176809A1 (en) * 2004-02-05 2005-08-11 Rodlen Laboratories, Inc. Method and compositions for treatment of painful disorders
WO2007140189A2 (en) * 2006-05-26 2007-12-06 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted carboxylic acid compounds
EP2068833B1 (de) * 2006-07-26 2013-01-09 The Board of Regents of the University of Texas System Parenterale zubereitungen phospholipid-assoziierter gi-sicherer entzündungshemmer, zubereitungsverfahren und verwendung
KR20140014350A (ko) * 2009-03-12 2014-02-06 큠버랜드 파마슈티컬즈 인코포레이티드 정맥 내 투여용 이부프로펜의 투여
US8871810B2 (en) * 2009-07-15 2014-10-28 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
US8735452B2 (en) * 2009-07-15 2014-05-27 Cumberland Pharmaceuticals Inc. Treating patients with intravenous ibuprofen
CA2766367A1 (en) * 2009-07-31 2011-02-03 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
US8415337B1 (en) 2011-03-06 2013-04-09 Recordati Rare Diseases Inc. Ibuprofen compositions and methods of making same
ES2422563B1 (es) * 2012-03-08 2014-06-10 Farmalider S.A. Composición farmacéutica inyectable de ibuprofeno y arginina, su procedimiento de preparación, forma de dosificación unitaria y utilización de la misma
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
US9072661B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
GR1008942B (el) * 2015-10-14 2017-02-06 ΙΟΥΛΙΑ ΚΑΙ ΕΙΡΗΝΗ ΤΣΕΤΗ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "INTERMED ΑΒΕΕ" Μεθοδος παραγωγης σταθερου υδατικου διαλυματος λυσινικης ιμπουπροφαινης για ενδοκολπικη χρηση
KR101924786B1 (ko) 2017-07-31 2018-12-04 주식회사 인트로바이오파마 이부프로펜의 주사용 약제학적 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1497044A (en) 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
DE3301328A1 (de) * 1982-02-01 1983-08-11 The Upjohn Co., 49001 Kalamazoo, Mich. Arzneimittel zur einleitenden bekaempfung von akuter oder chronischer, myelogener leukaemie
DE3328401A1 (de) 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren Injizierbare loesung zur behandlung von entzuendungen
JPH0647532B2 (ja) * 1983-08-31 1994-06-22 ジ アツプジヨン カンパニ− 歯槽骨吸収の治療
US4994604A (en) 1990-01-10 1991-02-19 Merck & Co., Inc. Formation and resolution of ibuprofen lysinate
DE69214333T2 (de) 1991-03-22 1997-04-24 Merck & Co Inc Arzneizubereitung mit hohem Gehalt an Ibuprofenlysinat
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
IT1264855B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
IT1277741B1 (it) 1995-12-28 1997-11-12 Dompe Spa Composizioni farmaceutiche parenterali contenenti sali di alchilammonio di acidi 2-arilpropionici

Also Published As

Publication number Publication date
EP1205181A3 (de) 2002-08-21
EP1205181B9 (de) 2005-07-27
EP1205181B1 (de) 2005-04-20
EP1205181A2 (de) 2002-05-15
MXPA01011629A (es) 2005-10-19
JP2002193799A (ja) 2002-07-10
CA2361160A1 (en) 2002-05-14
DE60110185T2 (de) 2006-03-09
DE60110185D1 (de) 2005-05-25
US6342530B1 (en) 2002-01-29

Similar Documents

Publication Publication Date Title
ATE293444T1 (de) Zusammensetzung und verfahren zur parenteralen anwendung von ibuprofen-d,l-, oder l-lysinat
EA200800161A1 (ru) Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций
KR900700089A (ko) 전신성 피부 투과적 투여를 위한 약학적 조성물
ATE267798T1 (de) Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
WO2003073981A3 (en) Novel of cytokine inhibitors
CY1115908T1 (el) Υγρη συνταγοποιηση προϊοντος συζευξης g-csf
DK1383540T3 (da) Fremgangsmdåer og farmaceutiske sammensætninger til sårheling
ES2125696T3 (es) Utilizacion del cloruro de tropsio para la produccion de una preparacion farmaceutica para el tratamiento de disfunciones vesicales.
ATE486599T1 (de) Pharmazeutische zusammensetzung mit amlodipinbesilat und lisinoprildihydrat und herstellungsverfahren dafür
BR0008776A (pt) Análogos de prostaglandinas fp-seletivosinsaturados c16
BR0013283A (pt) Agente farmacêutico que compreende um derivado de benzamida como ingrediente ativo
HRP20110370T1 (hr) Uporaba agomelatina za dobivanje lijeka u cilju liječenja smith-magenisovog sindroma
DE60026883D1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
RU2015114709A (ru) Стабильная композиция для инъекций, содержащая диклофенак и тиоколхикозид
RU2445083C1 (ru) Средство для лечения гнойно-воспалительных процессов мягких тканей и слизистых оболочек
DK1660495T3 (da) Benzoquinolizin-2-carboxylsyreargininsalt,tetrahydrat
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
RU2005104905A (ru) Способ лечения послеоперационных онкогинекологических больных и гель для его осуществления
RU2005100846A (ru) Фармацевтические соли ребоксетина
KR950702528A (ko) 엔^지(n^g)-모노메틸-엘(l)-아르기닌 염화수소 유도체 및 패혈증성 쇼크의 치료에 있어서의 이들의 용도, (n^g-monomethyl-l-arginine hydrochloride derivatives and their use in the treatment of septic shock)
HUP0301119A2 (hu) Bioaktiváló hatóanyag és gyógyszerkészítmény
DK0541726T3 (da) Vækstfaktorsammensætninger, fremstilling og anvendelse
DE69910706D1 (de) Medikament zur Behandlung von Glaukoma und ischämischer Retinopathie
DE602006016168D1 (de) 1,3,5-triazepin-dionen zur Behandlung von Malaria

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties